Insider Activity

An $8 million purchase of Ford's common stock was just made by William Clay Ford Jr. The move might not negate the last poor earnings announcement and guidance, but it may signal at least some safety...
Almost $2.4 million was spent by insiders to buy shares of American Airlines. This is a solid financial commitment by management after a period in which the share price has fallen handily from the...
There is a saying that nothing lasts forever, and that is what CenturyLink's management may be trying to communicate.
When it comes out that Carl Icahn is investing in a stock, those shares usually trade up. But what happens when he starts dialing down his holdings?
Nvidia just lost a serious long-time backer. Japan's SoftBank Group has disclosed that it sold its entire 4.9% stake in the tech company.
So what happens after a massive slide in IBM's share price and insiders have started buying the stock?
  After a big stock market sell-off and a subsequent snap-back rally, it’s always interesting to see how corporate directors are acting toward their own shares. It’s no secret that...
The ongoing Tesla saga keeps offering new twists and turns for both the company and its shareholders.
La Jolla Pharmaceutical and Sarepta Therapeutics are among seven biotech stocks that have seen some notable insider trading recently.
Several allies hit back at Trump tariffs, S&P cuts Deutsche Bank's credit rating, a Goldman Sachs executive charged with insider trading, and other important headlines.
Here are four battered companies that some big name investors and insiders are buying shares of now.
It seems that GE's recently appointed CEO, John Flannery, is taking an increased stake in the company in hopes that it will turn around. But is it too late?
There is legal insider trading, where corporate insiders have windows of time buy or sell shares in their companies. And then there is illegal insider trading, whereby privileged information is used...
Most of the large biotech outfits in America have gone into a limbo mode. Alexion Pharmaceuticals fits that bill despite its more than $26 billion market cap. Is it possible that some real good...
Another week in which insider buying dominated the insider selling. This remains incredibly positive for stock investors after an eight-year bull market.